Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Track income, expenses, savings, and debt payments to gain a clear view of your financial health and progress.
16,643 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
The Duquesne Family Office disclosed new and existing stakes in Arm Holdings, Sea Limited, and STMicroelectronics in ...
Oil weakness adds pressure on Chevron as analysts weigh earnings visibility and cash returns. A rising risk of a drop...
Five years after investing in KWEB, the math reveals a hard lesson about concentration, fee drag, and the complexity ...
Yum! Brands is selling Pizza Hut in two moves, reshaping its portfolio. This could boost balance sheet strength and s...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
A high-yield AI-focused ETF sounds tempting, but a big payout can hide risks. This article breaks down how the divide...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
SpaceX (SPCX) has fallen about 30% from its peak while planning a large debt raise. This guide breaks down what the d...
A top market analyst says the popular rotation narrative is flawed. New ETF flow data show bitcoin didn’t lose gold, ...
If you have $3,000 ready to invest, you can build a focused trio of growth, income, and stability. This guide shows t...
Ray Dalio’s Suez analogy returns to the headlines as markets weigh the U.S. risk of a reserve-currency shift and a we...